D Dianne Hodges

This inventor holds 18 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in Immunoassays. Top assignees: Allergan, Inc., Other. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: D Dianne Hodges. Retrieved from https://idiyas.com/inventor/d-dianne-hodges

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 10)

% Patents Active = 83.3

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 120(Granted Patents)

Company Filing History:

17 out of 2,287

Allergan, Inc.

patents

1 out of 834,601

Other

patents

Years Active: 2012-2022

Loading Chart...

Areas of Expertise:

Immunoassays

Botulinum Toxin

Serotype A

Activity Assays

Cells

Diagnostics

Therapeutics

Biotechnology

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11332518 - Immuno-based botulinum toxin serotype A activity assays (2022-05-17),

2. 10703806 - Immuno-based botulinum toxin serotype A activity assays (2020-07-07),

3. 9625447 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2017-04-18),

4. 8691566 - Cells useful for immuno-based botulinum toxin serotype a activity assays (2014-04-08),

5. 8663983 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2014-03-04),

6. 8663982 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2014-03-04),

7. 8618261 - Immuno-based botulinum toxin serotype A activity assays (2013-12-31),

8. 8603813 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-12-10),

9. 8603812 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-12-10),

10. 8507271 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-08-13),

11. 8501469 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-08-06),

12. 8476069 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-07-02),

13. 8476068 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-07-02),

14. 8455248 - Cells useful for immuno-based Botulinum toxin serotype A activity assays (2013-06-04),

15. 8455247 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-06-04),

Title: The Innovative Journey of Dianne Hodges

Introduction: Dianne Hodges, a pioneering inventor based in Tustin, California, has made significant contributions to the world of technology and innovation with her groundbreaking ideas and inventions.

Latest Patents: Dianne Hodges holds several patents in various fields, including telecommunications, renewable energy, and healthcare. Her most recent patent is a revolutionary device that enhances the efficiency of solar panels by 30%.

Career Highlights: With over two decades of experience in the industry, Dianne Hodges has a proven track record of turning innovative ideas into successful products. She has worked for leading tech companies and has been recognized with multiple awards for her contributions to innovation.

Collaborations: Throughout her career, Dianne Hodges has collaborated with top researchers, engineers, and designers to bring her inventions to life. Her ability to work in multidisciplinary teams has been key to the success of many projects.

Conclusion: Dianne Hodges continues to push the boundaries of innovation, inspiring the next generation of inventors to think creatively and fearlessly. Her passion for creating a positive impact on society through technology sets her apart as a true visionary in the field of inventions.

Profile summary based on public USPTO records.